Topics
High-grade gliomas | Treatment | Clinical trials | Berubicin
Home > Publications > Topics > High-grade gliomas > Treatment > Clinical trials > Berubicin
Conrad CA, Hsu SH, Thapar N, Maher EA, Cloughesy TF, Colman H,
Gilbert MR, Puduvalli VK, Madden T, Priebe W.
Phase
I trial and pharmacokinetic study of berubicin (RTA 744) in
patients with recurrent or refractory high-grade
gliomas.
Neurooncol
Adv. 2026 Jul 31;8(1):vdag150. doi:
10.1093/noajnl/vdag150. PMID:
42569309. ˍ